nach oben

Erschienen in:

30.08.2018 | Original Article

The antiviral alkaloid berberine ameliorates neuropathic pain in rats with peripheral nerve injury

verfasst von: Shaomin Yang, Zhijian Yu, Wuping Sun, Changyu Jiang, Xiyuan Ba, Qian Zhou, Donglin Xiong, Lizu Xiao, Qiwen Deng, Yue Hao

Erschienen in: Acta Neurologica Belgica | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Neuropathic pain is a major public health problem. There is a need to develop safer and more effective analgesia compounds with less side effects. Berberine has been used to treat diarrhea and gastroenteritis due to its anti-microbial, anti-motility and anti-secretory properties. Berberine has also been reported to play an analgesic role in some pathological conditions of pain. However, the analgesic roles of berberine in neuropathic pain are still unclear. Therefore, this study aims to explore the analgesic effects of berberine in neuropathic pain. Partial sciatic nerve ligation (pSNL) was performed to create neuropathic pain model. Paw withdrawal responses to mechanical and thermal stimuli were measured using a set of electronic von Frey apparatus and hot plate, respectively. The time that rats spent licking, flinching and lifting its paw during 5 min following capsaicin application was recorded. mRNA and protein expression levels were examined by quantitative RT-PCR and western blot, respectively. Berberine administration (i.p.) increased both mechanical and thermal pain thresholds in a dose-dependent manner. Moreover, berberine administration reversed the mRNA and protein expression of TRPV1 in dorsal root ganglion neurons after peripheral nerve injury. In addition, berberine significantly inhibited capsaicin-induced pain behaviors. The amelioration of neuropathic pain by berberine may be associated with the down-regulation of TRPV1 in DRG of neuropathic pain rats. This study highlighted the potential of berberine in the treatment of neuropathic pain originated in the peripheral nervous system.

Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DL, Bouhassira D, Cruccu G, Freeman R, Hansson P, Nurmikko T, Raja SN, Rice AS, Serra J, Smith BH, Treede RD, Jensen TS (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157(8):1599–1606. https://doi.org/10.1097/j.pain.0000000000000492 CrossRefPubMedPubMedCentral

Burke D, Fullen BM, Stokes D, Lennon O (2017) Neuropathic pain prevalence following spinal cord injury: a systematic review and meta-analysis. Eur J Pain 21(1):29–44. https://doi.org/10.1002/ejp.905 CrossRefPubMed

Baron R, Binder A, Wasner G (2010) Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9(8):807–819. https://doi.org/10.1016/s1474-4422(10)70143-5 CrossRefPubMed

Montell C, Rubin GM (1989) Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 2(4):1313–1323CrossRef

Nilius B (2007) Transient receptor potential (TRP) cation channels: rewarding unique proteins. Bulletin et memoires de l’Academie royale de medecine de Belgique 162(3–4):244–253PubMed

Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389(6653):816–824. https://doi.org/10.1038/39807 CrossRefPubMed

Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D (1998) The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21(3):531–543CrossRef

Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, Earley TJ, Hergarden AC, Andersson DA, Hwang SW, McIntyre P, Jegla T, Bevan S, Patapoutian A (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112(6):819–829CrossRef

Tominaga M, Caterina MJ (2004) Thermosensation and pain. J Neurobiol 61(1):3–12. https://doi.org/10.1002/neu.20079 CrossRefPubMed

10.

Caterina MJ, Julius D (2001) The vanilloid receptor: a molecular gateway to the pain pathway. Ann Rev Neurosci 24:487–517. https://doi.org/10.1146/annurev.neuro.24.1.487 CrossRefPubMed

11.

Kim YH, Back SK, Davies AJ, Jeong H, Jo HJ, Chung G, Na HS, Bae YC, Kim SJ, Kim JS, Jung SJ, Oh SB (2012) TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord. Neuron 74(4):640–647. https://doi.org/10.1016/j.neuron.2012.02.039 CrossRefPubMed

12.

Marrone MC, Morabito A, Giustizieri M, Chiurchiu V, Leuti A, Mattioli M, Marinelli S, Riganti L, Lombardi M, Murana E, Totaro A, Piomelli D, Ragozzino D, Oddi S (2017) TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice. Nat Commun 8:15292. https://doi.org/10.1038/ncomms15292 CrossRefPubMedPubMedCentral

13.

Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36(1):57–68CrossRef

14.

Jiang CY, Fujita T, Yue HY, Piao LH, Liu T, Nakatsuka T, Kumamoto E (2009) Effect of resiniferatoxin on glutamatergic spontaneous excitatory synaptic transmission in substantia gelatinosa neurons of the adult rat spinal cord. Neuroscience 164(4):1833–1844. https://doi.org/10.1016/j.neuroscience.2009.09.033 CrossRefPubMed

15.

Chen Y, Willcockson HH, Valtschanoff JG (2009) Influence of the vanilloid receptor TRPV1 on the activation of spinal cord glia in mouse models of pain. Exp Neurol 220(2):383–390. https://doi.org/10.1016/j.expneurol.2009.09.030 CrossRefPubMedPubMedCentral

16.

Lappin SC, Randall AD, Gunthorpe MJ, Morisset V (2006) TRPV1 antagonist, SB-366791, inhibits glutamatergic synaptic transmission in rat spinal dorsal horn following peripheral inflammation. Eur J Pharmacol 540(1–3):73–81. https://doi.org/10.1016/j.ejphar.2006.04.046 CrossRefPubMed

17.

Spicarova D, Palecek J (2008) The role of spinal cord vanilloid (TRPV1) receptors in pain modulation. Physiol Res 57(Suppl 3):S69–S77PubMed

18.

Biggs JE, Yates JM, Loescher AR, Clayton NM, Boissonade FM, Robinson PP (2007) Changes in vanilloid receptor 1 (TRPV1) expression following lingual nerve injury. Eur J Pain 11(2):192–201. https://doi.org/10.1016/j.ejpain.2006.02.004 CrossRefPubMed

19.

Kim HY, Park CK, Cho IH, Jung SJ, Kim JS, Oh SB (2008) Differential changes in TRPV1 expression after trigeminal sensory nerve injury. J Pain 9(3):280–288. https://doi.org/10.1016/j.jpain.2007.11.013 CrossRefPubMed

20.

Tao W, Luo X, Cui B, Liang D, Wang C, Duan Y, Li X, Zhou S, Zhao M, Li Y, He Y, Wang S, Kelley KW, Jiang P, Liu Q (2015) Practice of traditional Chinese medicine for psycho-behavioral intervention improves quality of life in cancer patients: a systematic review and meta-analysis. Oncotarget 6(37):39725–39739. https://doi.org/10.18632/oncotarget.5388 CrossRefPubMedPubMedCentral

21.

Yuan QL, Guo TM, Liu L, Sun F, Zhang YG (2015) Traditional Chinese medicine for neck pain and low back pain: a systematic review and meta-analysis. PloS One 10(2):e0117146. https://doi.org/10.1371/journal.pone.0117146 CrossRefPubMedPubMedCentral

22.

Li Q, Yue N, Liu SB, Wang ZF, Mi WL, Jiang JW, Wu GC, Yu J, Wang YQ (2014) Effects of chronic electroacupuncture on depression- and anxiety-like behaviors in rats with chronic neuropathic pain. Evid Based Comp Alter Med eCAM. https://doi.org/10.1155/2014/158987 CrossRef

23.

Chen C, Lu M, Pan Q, Fichna J, Zheng L, Wang K, Yu Z, Li Y, Li K, Song A, Liu Z, Song Z, Kreis M (2015) Berberine improves intestinal motility and visceral pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms in an opioid-receptor dependent manner. PloS One 10(12):e0145556. https://doi.org/10.1371/journal.pone.0145556 CrossRefPubMedPubMedCentral

24.

Chen C, Tao C, Liu Z, Lu M, Pan Q, Zheng L, Li Q, Song Z, Fichna J (2015) A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome. Phytother Res PTR 29(11):1822–1827. https://doi.org/10.1002/ptr.5475 CrossRefPubMed

25.

Mo C, Wang L, Zhang J, Numazawa S, Tang H, Tang X, Han X, Li J, Yang M, Wang Z, Wei D, Xiao H (2014) The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid Redox Signal 20(4):574–588. https://doi.org/10.1089/ars.2012.5116 CrossRefPubMedPubMedCentral

26.

Tan W, Li Y, Chen M, Wang Y (2011) Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. Int J Nanomed 6:1773–1777. https://doi.org/10.2147/IJN.S22683 CrossRef

27.

Kim SO, Kim HJ (2013) Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy. J Med Food 16(6):511–517. https://doi.org/10.1089/jmf.2012.2648 CrossRefPubMedPubMedCentral

28.

Sun W, Zhou Q, Ba X, Feng X, Hu X, Cheng X, Liu T, Guo J, Xiao L, Jiang J, Xiong D, Hao Y, Chen Z, Jiang C (2018) Oxytocin relieves neuropathic pain through GABA release and presynaptic TRPV1 inhibition in spinal cord. Front Mol Neurosci. https://doi.org/10.3389/fnmol.2018.00248 CrossRefPubMedPubMedCentral

29.

Wang ZL, Pan JX, Song JJ, Tang HH, Yu HP, Li XH, Li N, Zhang T, Zhang R, Zhang MN, Xu B, Fang Q, Wang R (2016) Structure-based optimization of multifunctional agonists for opioid and neuropeptide FF receptors with potent nontolerance forming analgesic activities. J Med Chem 59(22):10198–10208. https://doi.org/10.1021/acs.jmedchem.6b01181 CrossRefPubMed

30.

Chen G, Kim YH, Li H, Luo H, Liu DL, Zhang ZJ, Lay M, Chang W, Zhang YQ, Ji RR (2017) PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1. Nat Neurosci 20(7):917–926. https://doi.org/10.1038/nn.4571 CrossRefPubMedPubMedCentral

31.

Sun W, Uchida K, Suzuki Y, Zhou Y, Kim M, Takayama Y, Takahashi N, Goto T, Wakabayashi S, Kawada T, Iwata Y, Tominaga M (2016) Lack of TRPV2 impairs thermogenesis in mouse brown adipose tissue. EMBO Rep 17(3):383–399. https://doi.org/10.15252/embr.201540819 CrossRefPubMedPubMedCentral

32.

Malin S, Molliver D, Christianson JA, Schwartz ES, Cornuet P, Albers KM, Davis BM (2011) TRPV1 and TRPA1 function and modulation are target tissue dependent. J Neurosci 31(29):10516–10528. https://doi.org/10.1523/JNEUROSCI.2992-10.2011 CrossRefPubMedPubMedCentral

33.

Descalzi G, Mitsi V (2017) Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression. Sci Signal. https://doi.org/10.1126/scisignal.aaj1549 CrossRefPubMedPubMedCentral

34.

Ji RR, Chamessian A, Zhang YQ (2016) Pain regulation by non-neuronal cells and inflammation. Science 354(6312):572–577. https://doi.org/10.1126/science.aaf8924 CrossRefPubMedPubMedCentral

35.

Kuner R (2010) Central mechanisms of pathological pain. Nat Med 16(11):1258–1266. https://doi.org/10.1038/nm.2231 CrossRefPubMed

36.

Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, Markman JD, Oaklander AL, Polydefkis MJ, Raja SN, Robinson JP, Woolf CJ, Ziegler D, Ashburn MA, Burke LB, Cowan P, George SZ, Goli V, Graff OX, Iyengar S, Jay GW, Katz J, Kehlet H, Kitt RA, Kopecky EA, Malamut R, McDermott MP, Palmer P, Rappaport BA, Rauschkolb C, Steigerwald I, Tobias J, Walco GA (2015) Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain 156(7):1184–1197. https://doi.org/10.1097/j.pain.0000000000000191 CrossRefPubMedPubMedCentral

37.

Dworkin RH, O’Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, Kent JL, Krane EJ, Lebel AA, Levy RM, Mackey SC, Mayer J, Miaskowski C, Raja SN, Rice AS, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proc 85(3 Suppl):S3–S14. https://doi.org/10.4065/mcp.2009.0649 CrossRef

38.

Schwartz ES, La JH, Scheff NN, Davis BM, Albers KM, Gebhart GF (2013) TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis. J Neurosci 33(13):5603–5611. https://doi.org/10.1523/JNEUROSCI.1806-12.2013 CrossRefPubMedPubMedCentral

39.

Moriyama T, Iida T, Kobayashi K, Higashi T, Fukuoka T, Tsumura H, Leon C, Suzuki N, Inoue K, Gachet C, Noguchi K, Tominaga M (2003) Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci 23(14):6058–6062CrossRef

40.

Mandadi S, Tominaga T, Numazaki M, Murayama N, Saito N, Armati PJ, Roufogalis BD, Tominaga M (2006) Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCepsilon-mediated phosphorylation at S800. Pain 123(1–2):106–116. https://doi.org/10.1016/j.pain.2006.02.016 CrossRefPubMed

Titel: The antiviral alkaloid berberine ameliorates neuropathic pain in rats with peripheral nerve injury
verfasst von: Shaomin Yang
Zhijian Yu
Wuping Sun
Changyu Jiang
Xiyuan Ba
Qian Zhou
Donglin Xiong
Lizu Xiao
Qiwen Deng
Yue Hao
Publikationsdatum: 30.08.2018
Verlag: Springer International Publishing
Erschienen in: Acta Neurologica Belgica / Ausgabe 3/2020
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-018-1006-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The antiviral alkaloid berberine ameliorates neuropathic pain in rats with peripheral nerve injury

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

A mysterious white matter lesion

Early-onset progressive encephalopathy associated with NAXE gene variants: a case report of a Turkish child

Graft-versus-host disease-related neuropathy: AMAN phenotype with improvement after plasmapheresis

Simulating glioblastoma growth consisting both visible and invisible parts of the tumor using a diffusion–reaction model followed by resection and radiotherapy

Adrenergic hyperactivity: a missing link between multiple sclerosis and cardiovascular comorbidities?

Molecular insights into the role of AMPA receptors in the synaptic plasticity, pathogenesis and treatment of epilepsy: therapeutic potentials of perampanel and antisense oligonucleotide (ASO) technology

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie